Abstract
Cervical cytologic screening and early management of abnormal pap smears played an important role in reducing invasive cervical cancer incidence and mortality over the past decades. Despite widely available cost effective screening for cervical cancer in the United States, women in lower socioeconomic groups and minorities continue to suffer from a higher incidence and mortality from cervical cancer and national goals have not been met. The biological, psychosocial, and cultural barriers that contribute to these disparities will be reviewed. This article also reviews current screening methodologies, treatment algorithms and newer developments that hold additional promise for the future of cervical cancer prevention.
Keywords: cervical cancer, pap test, human papillomavirus, infection
Call for Papers in Thematic Issues
RARE CASES IN GYNECOLOGY-OBSTETRICS
With the development of diagnostic and therapeutic techniques (such as ART techniques) and the immersion of new pathologies (such as COVID19), we are witnessing an increase in the incidence of pathologies that were previously described as rare or exceptional. the practitioner sometimes confronts difficult situations in these cases in diagnostic ...read more
10